Markets
Rider hanging on to bucking bull
Getty Images

If April was “Sell America” month, June was “Buy America” month — and it was 9x the size

Retail traders aren’t the only ones buying the dip in this bull market, as foreign investors plowed $163 billion into US equities in June, the most on record.

8/19/25 9:59AM

Much has been made of the “Sell America” trade, as President Trump’s “Liberation Day” in early April upended notions of what global trade norms should be, sending stocks and the US dollar tumbling.

But the truth is that “Sell America” — the idea that investors were redrawing the world in their heads, reacting to a seismic shift in the global order — never really happened. Or, if it did, it was A) very brief, and B) more of a currency market phenomenon than a stock market one.

Treasury International Capital data, reported by Cameron Crise at Bloomberg on Monday, reveals that foreign investors have plowed $279 billion (net) back into US equities in the last two months, with $163 billion in June alone — the highest monthly figure ever.

Net Buyers
Sherwood News

For context, in April, net flows out of US equities totaled $18.4 billion; June’s buying was 8.9x that figure.

Indeed, tariffs have become old news. Recession risks have receded, the AI boom has barely blinked, and any lingering trade issues in supply chains are being lumped into the “solvable” category of jobs to be done. That’s given the green light for global investors to run the same playbook that retail traders have been employing: buy each and every dip.

No wonder the direction of travel has been so remarkable, with the S&P 500 Index rising 29% since April 8.

Sell some of America?

Interestingly, this has been more of an equity story than anything else. Treasurys continue to reflect more of a US inflation and policy uncertainty premium, with 30-year yields at 4.91%, and there have been negligible flows into US government bonds in recent months, with fiscal concerns still fresh in many minds.

Of course, the US Dollar Spot Index itself remains down roughly 10% for the year. So from the perspective of foreign buyers, the S&P 500 is roughly flat year to date.

In all, the “Sell America” story looks to have been more a case of large foreign institutions electing to hedge the ample US dollar exposure they already have rather than dump those American assets.

A recent Morgan Stanley analysis suggest that Danish pension funds and insurers, the only cohort with detailed data available post-April, shows that hedge ratios (or the share of US dollar assets that are insulated from currency fluctuations) rose since the start of the year, but “remained flat between May and June.”

As long as the US equity market contains the AI-exposed tech giants, and as long those AI names continue to power both the economy and corporate earnings, it’s hard to see the world really embracing the “Sell America” idea in US stocks en masse.

Of course, people will always look for reasons to sell — and there is nothing like looking, if you want to find something. For now, concerns about stretched valuations seem to garner the most agreement (typically just before the market hits a new, more expensive high).

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.